Honasa Consumer Limited Enters Nutraceuticals with Majority Stake Acquisition in Fluence Pharma

M&A / JV 23 Jun 2026 · Announced· ✓ Verified

Honasa Consumer Limited announced the acquisition of a majority stake in Fluence Pharma, a nutraceuticals manufacturer, on 23 June 2026. The transaction represents Honasa's strategic expansion from its core beauty and personal care e-commerce business into the adjacent, high-margin nutraceuticals segment. The acquisition structure, consideration amount, and earnout/holdback terms remain undisclosed in the press release; completion was subject to standard regulatory approvals and closing conditions.

Why it mattersThe deal signals consolidation in the India nutraceuticals sector via strategic M&A by listed e-commerce players seeking vertical integration; valuation and consideration structure will set precedent for similar beauty-to-wellness vertical pivots in consumer goods M&A.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals